In a recent tweet from the International Society for Pharmacoepidemiology (@ICPE) it was stated from a company that they had the only validated real-world evidence platform that enables reproducible, transparent safety and effectiveness analysis at any scale. It is unclear what this company’s perspective was, perhaps they have not bothered to look around them or are hidden by their own ego, to announce that they are the ONLY validated data set. It is a very important discussion about the quality of the data-sets being used. But there are many more validated data-sets.
Here is a snapshot from Denmark, as an example to demonstrate that there are other data-sets that have been validated or where the validity has been assessed. There are many other validated data sets from other countries, some of which we have discussed in our previous blog posts.
- Jensen TB, Jimenez-Solem E, Cortes R, Betzer C, Bøge Breinholt S, Meidahl Petersen K, et al. Content and validation of the Electronic Patient Medication module (EPM)—the administrative in-hospital drug use database in the Capital Region of Denmark. Scandinavian Journal of Public Health. 2018 Mar;140349481876005.
- Johannesdottir SA, Horváth-Puhó E, Ehrenstein V, Schmidt M, Pedersen L, Sørensen HT. Existing data sources for clinical epidemiology: The Danish National Database of Reimbursed Prescriptions. Clin Epidemiol. 2012;4:303–13.
- Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–90.
- Nielsen LH, Nørgaard BL, Tilsted HH, Sand NP, Jensen JM, Bøttcher M, et al. The Western Denmark Cardiac Computed Tomography Registry: a review and validation study. Clin Epidemiol. 2015;7:53–64.